Potential stakeholders that might be adversely affected include:
- Pharmacy - antimicrobial stewardship committees
- Infection prevention and control - committees documenting trends within a facility
- Provider networks - prescribing physicians and clinicians
- Other facilities within the laboratory's network (e.g., multiple hospitals)
These stakeholders guide the institution's internal and external working mechanisms; patient safety may be at risk if any one of these groups ignores the use of current nomenclature.
